# Body Composition Metrics Associated with Time to Progression in Smoldering Multiple Myeloma

**Authors:** Fabian Bauer, Florian A. Huber, Marilyn E. Galdamez, Ivanna Zorgno, Sina Habibollahi, Amine El Kandoussi, Florian J. Fintelmann, P. Erik Tonnesen, Anna-Sophia W. Dietrich, Zhe Wang, Adam Graeber, Robert D. Boutin, Leon Lenchik, Joshua N. Gustine, Steven J. Staffa, Noopur Raje, Connie Y. Chang

PMC · DOI: 10.3390/diagnostics15212760 · Diagnostics · 2025-10-31

## TL;DR

This study finds that higher subcutaneous fat levels in people with smoldering multiple myeloma are linked to slower disease progression.

## Contribution

The study identifies subcutaneous adipose tissue metrics as potential prognostic markers in smoldering multiple myeloma.

## Key findings

- Higher subcutaneous adipose tissue cross-sectional area is associated with longer time to progression.
- SAT indexed to height also correlates with delayed disease progression.
- SAT metrics remain significant in multivariate analysis after adjusting for other factors.

## Abstract

Objective: To determine the association of body composition (BC) in smoldering multiple myeloma (SMM) with time to progression (TTP) to MM. Methods: The quantity and quality of adipose and muscle tissue were retrospectively derived from 63 whole-body low-dose computed tomography (WBLDCT) scans between 2017 and 2021. BC was analyzed by segmenting a single axial image at the level of the fourth lumbar vertebrae. Subjects were grouped into below vs. above the sex-specific median for BC metrics. Clinical information including TTP and progression risk factors were recorded. Cox proportional hazard models were used to determine the association between BC metrics and TTP. BC groups were compared using the Wilcoxon rank sum test and Fisher’s exact test. Results: Thirty subjects progressed over a median follow-up of 49.2 months. For subjects with a subcutaneous adipose tissue (SAT) cross-sectional area (CSA) below vs. above the median, TTP was 24.8 vs. not reached (p = 0.02). Similarly, TTP was 20.7 vs. not reached (p = 0.01) for those with SAT CSA indexed to height below vs. above the median. High SAT CSA (hazard ratio [HR]: 0.42 [95%CI: 0.20–0.90], p = 0.03) and high SAT index (HR: 0.39 [95%CI: 0.18–0.83], p = 0.01) were both associated with a lower progression risk. High SAT index remained significantly associated with reduced progression risk in multivariate analysis (p = 0.03). There was no association between TTP and obesity (BMI ≥ 30 kg/m2) or muscle metrics. High SAT CSA and index were associated with younger age and higher hemoglobin levels. Conclusions: SAT quantity might serve as a prognostic marker for progression in SMM.

## Linked entities

- **Diseases:** multiple myeloma (MONDO:0009693), smoldering multiple myeloma (MONDO:0005235)

## Full-text entities

- **Diseases:** obesity (MESH:D009765), Multiple Myeloma (MESH:D009101), SMM (MESH:D000075122)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12607496/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12607496/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC12607496/full.md

---
Source: https://tomesphere.com/paper/PMC12607496